CTI BioPharma Corp $2.66

down -0.13


18/9/2014 04:00 PM  |  : CTIC  
Industries :
Get Trend Analysis Icon Get CTIC Trend Analysis - it has outperformed the S&P 500 by 66%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...

    GuruFocus
  3. After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, ...

    Benzinga
  4. Earnings Scheduled For March 4, 2014

    Benzinga
  5. Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, ...

    Benzinga
  6. This Week's Sector Gainers And Losers

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from ...

    Benzinga
  9. Cell Therapeutics Announces Removal of Partial Clinical Hold on Tosedostat

    Benzinga
  10. Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing ...

    Benzinga
  11. Cell Therapeutics Presents Interim Results from Phase 2 Tosedostat Trial ...

    Benzinga
  12. Cell Therapeutics Announces Results from Preclinical Study of Pixantrone ...

    Benzinga
  13. US Stock Futures Signal Lower Start On Wall Street

    Benzinga
  14. Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal ...

    Benzinga
  15. A Peek Into The Market Before The Trading Starts

    Benzinga
  16. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  17. Cell Therapeutics Says Study Achieved Endpoint Compared to Other Trials

    Benzinga
  18. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus
  19. Will Cell Therapeutics Stay Above New-Found Support?

    SchaeffersResearch
  20. Bears Set the Bar Low for Cell Therapeutics

    SchaeffersResearch
  21. Cell Therapeutics Prices Offering at $1.40/Common Share

    Benzinga
  22. Stocks End Mixed as Spanish Concerns Linger with General Motors (GM) and ...

    MarketIntelligenceCenter
  23. Morning Market Movers

    Benzinga
  24. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 1 ...

    GuruFocus
  25. Cell Therapeutics' Highly Selective Oral JAK 2 Inhibitor, Pacritinib, Demonstrates ...

    Benzinga
  26. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 4 ...

    GuruFocus
  27. Highs & Lows: Cell Therapeutics, Toll Brothers, Travelers, and Valero Energy

    SchaeffersResearch
  28. Morning Market Movers

    Benzinga
  29. Cell Therapeutics Says Holders Approve SBio Transaction

    Benzinga
  30. Hertz Global Holdings, Zalicus Among Stocks Gapping Up Monday

    FoxBusiness
  31. Ubiquiti Networks, Office Depot Among Stocks falling to Annual Lows Monday

    FoxBusiness
  32. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 5 ...

    GuruFocus
  33. TreeHouse Foods, Alexco Resource Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness
  34. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus
  35. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 5 ...

    GuruFocus
  36. Deckers Outdoor, Diamond Foods Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness
  37. Donaldson Company, Rovi Corporation Among Stocks falling to Annual Lows ...

    FoxBusiness
  38. Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to ...

    Benzinga
  39. European Medicines Agency's Committee For Medicinal Products For Human ...

    Benzinga
  40. These 4 Biotech Stocks Are a Buy Now

    GuruFocus
  41. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus
  42. Rodman & Renshaw Places Cell Therapeutics Under Review

    Benzinga
  43. Morning Market Losers

    Benzinga
  44. Cell Therapeutics Plummeting on NDA Withdrawl

    Benzinga
  45. From Earlier: Cell Therapeutics Withdraws New Drug Application for Pixuvri ...

    Benzinga
  46. Solar Stocks to watch in the week ahead

    Benzinga
  47. From Earlier: Cell Therapeutic Announces FDA's Oncologic Drugs Advisory ...

    Benzinga
  48. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus
  49. Call Players Focus Some Attention on Cell Therapeutics

    SchaeffersResearch
  50. Stocks To Watch For December 12

    Benzinga
Trading Center